Analystreport

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Robert W. Baird from $117.00 to $125.00.

Neurocrine Biosciences, Inc.  (NBIX) 
Last neurocrine biosciences, inc. earnings: 2/4 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: neurocrine.com/about-us/webcasts-presentations